Home › Compare › CTCXW vs PLD

CTCXW vs PLD: Dividend Comparison 2026

CTCXW yields 7490.64% · PLD yields 3.10%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 CTCXW wins by $3219325239215187.00M in total portfolio value
10 years
CTCXW
CTCXW
● Live price
7490.64%
Share price
$0.03
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$3219325239215192.50M
Annual income
$3,136,944,464,329,217,000,000.00
Full CTCXW calculator →
PLD
PLD
● Live price
3.10%
Share price
$132.18
Annual div
$4.10
5Y div CAGR
74.4%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$5.91M
Annual income
$4,750,725.19
Full PLD calculator →

Portfolio growth — CTCXW vs PLD

📍 CTCXW pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodCTCXWPLD
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, CTCXW + PLD cover 0 of 12 months — good coverage

Jan
—
Feb
—
Mar
—
Apr
—
May
—
Jun
—
Jul
—
Aug
—
Sep
—
Oct
—
Nov
—
Dec
—
CTCXW pays
PLD pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

CTCXW
Annual income on $10K today (after 15% tax)
$636,704.12/yr
After 10yr DRIP, annual income (after tax)
$2,666,402,794,679,834,000,000.00/yr
PLD
Annual income on $10K today (after 15% tax)
$263.66/yr
After 10yr DRIP, annual income (after tax)
$4,038,116.41/yr
At 15% tax rate, CTCXW beats the other by $2,666,402,794,679,830,000,000.00/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of CTCXW + PLD for your $10,000?

CTCXW: 50%PLD: 50%
100% PLD50/50100% CTCXW
Portfolio after 10yr
$1609662619607599.25M
Annual income
$1,568,472,232,164,610,800,000.00/yr
Blended yield
97.44%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on PLD right now

CTCXW
No analyst data
Altman Z
-38.0
Piotroski
4/9
PLD
Analyst Ratings
25
Buy
16
Hold
1
Sell
Consensus: Buy
Price Target
$136.00
+2.9% upside vs current
Range: $119.00 — $155.00
Altman Z
1.9
Piotroski
5/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

CTCXW buys
0
PLD buys
0
No recent congressional trades found for CTCXW or PLD in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricCTCXWPLD
Forward yield7490.64% ✓3.10%
Annual dividend / share$2.00$4.10 ✓
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%74.4% ✓
Portfolio after 10y$3219325239215192.50M ✓$5.91M
Annual income after 10y$3,136,944,464,329,217,000,000.00 ✓$4,750,725.19
Total dividends collected$3213812604182292.00M ✓$5.78M
Payment frequencyquarterlyquarterly
SectorStockREIT

Year-by-year: CTCXW vs PLD ($10,000, DRIP)

YearCTCXW PortfolioCTCXW Income/yrPLD PortfolioPLD Income/yrGap
1← crossover$759,764$749,063.67$11,241$540.96+$748.5K → CTCXW
2$54,000,925$53,187,977.91$13,019$991.13+$53.99M → CTCXW
3$3,590,852,097$3,533,071,107.68$15,801$1,870.97+$3590.84M → CTCXW
4$223,408,125,107$219,565,913,362.68$20,609$3,701.21+$223408.10M → CTCXW
5$13,005,862,347,544$12,766,815,653,679.31$29,919$7,867.97+$13005862.32M → CTCXW
6$708,523,022,229,903$694,606,749,518,031.20$50,631$18,617.74+$708523022.18M → CTCXW
7$36,122,824,222,390,480$35,364,704,588,604,476.00$105,528$51,352.20+$36122824222.28M → CTCXW
8$1,723,706,063,164,109,000$1,685,054,641,246,151,400.00$287,364$174,449.42+$1723706063163.82M → CTCXW
9$76,991,378,398,107,710,000$75,147,012,910,522,120,000.00$1,081,760$774,280.77+$76991378398106.63M → CTCXW
10$3,219,325,239,215,192,500,000$3,136,944,464,329,217,000,000.00$5,908,209$4,750,725.19+$3219325239215187.00M → CTCXW

CTCXW vs PLD: Complete Analysis 2026

CTCXW — Stock

Carmell Therapeutics Corporation focuses on the development of plasma-based bioactive material (PBM) to stimulate tissue repair or growth after injury, disease, and aging. Its lead product candidate is CT-101 bone healing accelerant for tibia fracture healing, foot/ankle fusion, spinal fusion, dental bone graft substitute, and bone void filler; and tissue healing accelerant for androgenetic alopecia and chronic wound healing. The company was founded in 2008 and is based in Pittsburgh, Pennsylvania.

Full CTCXW Calculator →

PLD — REIT

Prologis, Inc. is the global leader in logistics real estate with a focus on high-barrier, high-growth markets. As of December 31, 2020, the company owned or had investments in, on a wholly owned basis or through co-investment ventures, properties and development projects expected to total approximately 984 million square feet (91 million square meters) in 19 countries. Prologis leases modern logistics facilities to a diverse base of approximately 5,500 customers principally across two major categories: business-to-business and retail/online fulfillment.

Full PLD Calculator →
📬

Get this CTCXW vs PLD comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

CTCXW vs SCHDCTCXW vs JEPICTCXW vs OCTCXW vs KOCTCXW vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.